Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B known ✓ | P49841 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL31704957 | 1.00 | OPRM1 (0.34) | OPRM1HDAC2GSK3BDYRK1AHDAC1 | |
| Lithium Ion SCHEMBL31704782 | 0.89 | TBK1 (0.35) | OPRM1HDAC2 | |
| Lithium Ion SCHEMBL31705265 | 0.89 | TBK1 (0.35) | OPRM1HDAC2 | |
| SCHEMBL31706354 | 0.84 | OPRM1 (0.37) | OPRM1HDAC2GSK3BDYRK1A | |
| Lithium Ion SCHEMBL31706302 | 0.83 | ALDH1A1 (0.38) | OPRM1 | |
| Lithium Ion SCHEMBL31705586 | 0.83 | ALDH1A1 (0.38) | OPRM1 | |
| Lithium Ion SCHEMBL31706495 | 0.74 | TLR9 (0.43) | OPRM1 | |
| Lithium Ion SCHEMBL31705410 | 0.74 | TLR9 (0.43) | OPRM1 | |
| SCHEMBL31704665 | 0.74 | TBK1 (0.38) | OPRM1HDAC2 | |
| Lithium Ion SCHEMBL31704516 | 0.71 | KIT (0.45) | GSK3BDYRK1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025215110-A1 | NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS | LES LABORATOIRES SERVIER (FR) | 2025-10-16 | — | — | WO | disclosed |